Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

Delayed Quote. Delayed  - 08/22 05:35:06 pm
313 GBp   -0.32%
08/11 ADVANCED MEDICA : Notice of Results
06/27 ADVANCED MEDICA : Holdings in Company
05/26 ADVANCED MEDICA : Holdings in Company
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales63,068,682,689,998,3108
EBITDA17,919,922,125,228,031,4
Operating profit (EBIT)15,617,419,522,625,428,1
Pre-Tax Profit (EBT)15,217,019,122,525,327,6
Net income12,914,115,717,920,121,8
P/E ratio20,627,130,037,133,230,8
EPS (GBp )6,086,687,388,459,4510,2
Dividend per Share (GBp )0,700,800,921,031,131,20
Yield0,56%0,44%0,41%0,33%0,36%0,38%
Reference price (GBp )125.25181.25221.75314314314
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt------
Finance17,334,251,126,733,367,2
Operating income (EBITDA)17,919,922,125,228,031,4
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,481,911,522,532,532,53
Book Value Per Share (BVPS)44,8 PNC49,6 PNC59,1 PNC65,7 PNC74,1 PNC77,2 PNC
Cash Flow per Share7,83 PNC10,1 PNC9,33 PNC6,10 PNC8,60 PNC9,30 PNC
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 666 M GBP -
Entreprise Value (EV) 639 M GBP 633 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 37,1x 33,2x
Capitalization / Revenue 7,41x 6,78x
EV / Revenue 7,11x 6,44x
EV / EBITDA 25,4x 22,6x
Yield (DPS / Price) 0,33% 0,36%
Price to book (Price / BVPS) 4,78x 4,24x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 25,2% 25,9%
operating Leverage (Delta EBIT / Delta Sales) 1,84x 1,33x
Net Margin (Net Profit / Revenue) 19,9% 20,4%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 12,4% 12,5%
Rate of Dividend 12,2% 12,0%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,82% 2,58%
Cash Flow / Sales 14,4% 18,6%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -1,06x -1,19x
EPS & Dividend